Merck KGaA has successfully completed an EXCiPACT audit, which ensures current GMP and GDP requirements for pharmaceutical excipients through a certification process covering quality management systems, manufacturing, testing and release, and storage and distribution. The certification is designed to reduce the time and costs for pharma companies to comply with GMP regulations, as well as help secure the excipient supply chain.   “Thousands of excipients are present in medicines and the qu...